Anti-CSF2Ra/GM-CSFRa/CD116 Antibody (Mavrilimumab)
Catalog No.
F2049
Anti-CSF2Ra/GM-CSFRa/CD116 Antibody (Mavrilimumab)
Featured Products
Mavrilimumab (CAM 3001) is a monoclonal antibody that binds to the alpha subunit of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor and blocks intracellular signaling downstream of GM-CSF. GM-CSF may be a mediator of the overactive inflammatory response associated with respiratory failure and death.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.2 kDa
Dry ice
1085337-57-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
CAM-3001, KPL-301
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P15509
Human, Cynomolgus
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD116 His at 2 ug/mL can bind Anti-CSF2Ra/GM-CSFRa/CD116 Antibody (Mavrilimumab)
CSF2Ra / GM-CSFRa / CD116
Please avoid freeze-thaw cycles.